Compare RAY & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAY | BGLC |
|---|---|---|
| Founded | 1993 | 2017 |
| Country | Hong Kong | Malaysia |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 10.1M |
| IPO Year | 2024 | N/A |
| Metric | RAY | BGLC |
|---|---|---|
| Price | $4.19 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 81.4K | 33.1K |
| Earning Date | 07-24-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | $9,391,194.00 | ★ $9,465,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.88 | ★ N/A |
| Revenue Growth | N/A | ★ 2.21 |
| 52 Week Low | $1.40 | $1.92 |
| 52 Week High | $58.88 | $15.60 |
| Indicator | RAY | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 30.43 |
| Support Level | $3.81 | $1.92 |
| Resistance Level | $4.47 | $2.91 |
| Average True Range (ATR) | 0.40 | 0.20 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 65.03 | 19.47 |
Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.